New digital tool aims to transform MS monitoring
NCT ID NCT05949580
Summary
This study is testing a new digital platform designed to help doctors better monitor and manage people with relapsing-remitting multiple sclerosis (MS). The platform includes an app for patients to track their health and a system for doctors to analyze brain scans using artificial intelligence. Researchers will follow 500 participants for two years to see how easy the system is to use and whether it improves care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
-
Jersey Shore University Medical Centre
RECRUITINGNeptune City, New Jersey, 07753, United States
-
Minneapolis Clinic of Neurology
RECRUITINGGolden Valley, Minnesota, 55422, United States
-
Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim
RECRUITINGSinsheim, 74889, Germany
-
Universitaetsklinikum Carl Gustav Carus an der TU Dresden
RECRUITINGDresden, 01307, Germany
Conditions
Explore the condition pages connected to this study.